Myths, mystique, and misconceptions of venous disease

Journal of Vascular Surgery

Volumn 34, Issue 5, 2001, Pages 765-773

  Comerota, Anthony J ^a,b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

CHRONIC VEIN INSUFFICIENCY; FEMORAL VEIN; FIBRINOLYTIC THERAPY; HUMAN; MAST SUIT; REVIEW; VASCULAR DISEASE; VEIN INSUFFICIENCY; VEIN THROMBOSIS;

ANTICOAGULANTS; FEMORAL VEIN; GRAVITY SUITS; HUMANS; POSTPHLEBITIC SYNDROME; THROMBOLYTIC THERAPY; VASCULAR DISEASES; VENOUS INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 0035511733     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.116099     Document Type: Article

References (61)

1. Nicolaides AN, Hussein MK, Szendro G, Christopoulos D, Vasdekis S, Clarke H. The relation of venous ulceration with ambulatory venous pressure measurements. J Vasc Surg 1993;17:414-9.
2. Pollack AA, Taylor BE, Myers TT, Wood EH. The effect of exercise and body position on the venous pressure at the ankle in patients having venous valvular defects. J Clin Invest 1949;28:559-63.
3. Shull KC, Nicolaides AN, Fernandes E, Fernandes J, Miles C, Horner J, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg 1979;114:1304-6.
4. Johnson BF, Manzo RA, Bergelin RO, Strandness DE. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one-to-six year follow up. J Vasc Surg 1995;21:307-13.
5. Raju S, Fredericks R. Venous obstruction: an analysis of 137 cases with hemodynamic, venographic, and clinical correlations. J Vasc Surg 1991;13:91-100.
6. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinicopathological study in injured and burned patients. Br J Surg 1961;48:475-89.
7. 2 in venous valve pockets: its possible bearing on thrombogensis. Br J Surg 1981;68:166-70.
8. Stone EA, Stewart GJ. Architecture and structure of canine veins with special reference of confluences. Anat Rec 1988;222:154-63.
9. Schaub RG, Lynch PR, Stewart GJ. The response to canine veins to three types of abdominal surgery: a scanning and transmission electron microscopic study. Surgery 1978;83:411-24.
10. Stewart GJ, Alburger PD Jr, Stone EA, Soszka TW. Total hip replacement induces injury to remote veins in a canine model. J Bone Joint Surg 1983;65A:97-102.
11. Comerota AJ, Stewart GJ. Operative venous dilation and its relation to post operative deep venous thrombosis. In: Goldhaber SZ, editor. Prevention of venous thromboembolism. New York: Marcel Dekker; 1993. p. 25-50.
12. Comerota AJ, Stewart GJ, Alburger PD, Smalley K, White JV. Operative venodilation, a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery 1989;106:301-9.
13. Stewart GJ, Lachman JW, Alburger PD, Ziskin MC, Philips CM, Jensen K. Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or knee replacement. Ultrasound Med Biol 1990;16:133-40.
14. Bundens WP, Bergan JJ, Halasz NA, Murray J, Drehobl M. The superficial femoral vein. A potentially lethal misnomer. JAMA 1995; 274:1296-8.
15. Homans J. Exploration and division of the femoral and iliac veins in the treatment of thrombophlebitis of the leg. N Engl J Med 1941; 224:179-86.
16. Goss CM, editor. Gray's anatomy. 28th ed. Philadelphia: Lea & Febiger; 1966.
17. Ellis H. Clinical anatomy. 4th ed. Philadelphia: FA Davis Co; 1969.
18. Meissner MH, Caps MT, Bergelin RO, Manzo RA, Strandness DE Jr. Early outcome after isolated calf vein thrombosis. J Vasc Surg 1997; 26:749-56.
19. Comerota AJ. Acute deep venous thrombosis. In: Gloviczki P, Yao JST, editors. Handbook of venous disorders: guidelines of the American Venous Forum. New York: Chapman & Hall Medical; 1996. p. 243-59.
20. Lohr JM, Kerr TM, Lutter KS, Cranley RD, Spirtoff K, Cranley JJ. Lower extremity calf thrombosis: to treat or not to treat? [published correction appears in J Vasc Surg 1992;15:323]. J Vasc Surg 1991; 14:618-23.
21. Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet 1985;7:515-8.
22. Sawicki PT. Working group for the study of patient self-management of oral anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. JAMA 1999;281:145-50.
23. Beyth RJ, Landefeld CS. Prevention of major bleeding in older patients treated with warfarin: results of a randomized trial [abstract]. J Gen Intern Med 1997;12:66.
24. Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 1994;154:1945-53.
25. Horstkotte D, Piper C, Wiemer M. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy [abstract]. Eur Heart J 1996;17(suppl):230.
26. Conte RR, Kehoe WA, Nielson N, Lodhia H. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm 1986;43:2460-4.
27. Seabrook GR, Karp D, Schmitt DD, Bandyk DF, Towne JB. An outpatient anticoagulation protocol managed by a vascular nurse clinician. Am J Surg 1990;160:501-4.
28. Ansell J, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-9.
29. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1966; 348:423-8.
30. Gray DR, Garabediam-Ruffalo SM, Chretien SD. Cost justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intel Clin Pharm 1985;19:575-80.
31. Lucas FV, Duncan A, Jay R, Coleman R, Craft P, Chan B, et al. A novel whole blood capillary technique for measuring prothrombin time. Am J Clin Pathol 1987;88:442-6.
32. Yano Y, Kambayashi J, Murata K, Shiba E, Sakon M, Kawasaki T, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res 1992;66:583-90.
33. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 1989;8:864-7.
34. White RH, McCurdy SA, von Marensdorff H, Woodruff DE Jr, Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy: a randomized, prospective study. Ann Intern Med 1989;111:730-7.
35. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993;46:299-303.
36. Ageno W, Turpie AG. A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy. J Thromb Thrombolysis 1998;5(suppl 1):S69.
37. Poller L, Shiach CR, MacCallum P, Johansen AM, Munster AM, Magalhaes A, et al. Multicenter randomized study of computerized anticoagulant dosage. European Concerted Action on Anticoagulation (ECAA). Lancet 1998;352:1505-9.
38. Salzman EW, McManama GP, Shapiro AH, Robertson LK, Donovan AS, Blume HW, et al. Effect of optimization of fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression. Ann Surg 1987;206:636-41.
39. Jacobs DG, Piotrowski JJ, Hoppensteadt DA, Salvator AE, Fareed J. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996;40:710-16.
40. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, et al. The fibrinolytic effects of intermittent pneumatic compression. Ann Surg 1997;226:306-14.
41. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. J Vasc Surg 2000;32:537-43.
42. Davies MC, Hagen PO. The vascular endothelium, a new horizon. Ann Surg 1993;218:593-609.
43. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arterioscl Thromb Vasc Biol 1999;19:2812-7.
44. Sasahara AA, Llyers TM. The Urokinase Pulmonary Embolism Trial. A national cooperative study. Circulation 1973;39:SII-1-108.
45. Urokinase-Streptokinase Embolism Trial. Phase 2 results. A cooperative study. JAMA 1974;229:1606-13.
46. Sharma GVRK, Burleson VA, Sashara AA. Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism. N Engl J Med 1980;303:842-5.
47. Sharma GVRK, Boland ED, McIntyre KM, Sasahara AA. Long-term hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease [abstract]. J Am Coll Cardiol 1990;15:65A.
48. Tebbe U, Graf A, Kamke W, Zahn R, Forycki F, Kratzsch G, et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 1999;138:39-44.
49. Petitpretz P, Simmoneau G, Cerrina J, Musset D, Dreyfus M, Vandenbroek MD, et al. Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial. Circulation 1984;80:861-6.
50. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol 1992;20:520-6.
51. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507-11.
52. Konstantinides S, Geibel A, Olschweski M, Heinrich F, Grosser K, Rauber K, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 1997;96:882-8.
53. Plate G, Einarsson E, Ohin P, Jensen R, Qvarfordt P, Eklof B, et al. Thrombectomy with temporary arteriovenous fistula in acute iliofemoral venous thrombosis. J Vasc Surg 1984;1:867-76.
54. Plate G, Akesson H, Einarsson E, Ohlin P, Eklof B. Long-term results of venous thrombectomy combined with a temporary arteriovenous fistula. Eur J Vasc Surg 1990;4:483-9.
55. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute iliofemoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990;4:43-8.
56. O'Donnell TF, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977;22:483-8.
57. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-602.
58. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulous N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep vein thrombosis: report of a national multicenter registry. Radiology 1999;211:39-49.
59. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA Jr, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Intervent Radiol 1997;8:405-18.
60. Mathias SD, Prebil LA, Putterman CG, Chmiel JJ, Throm RC, Comerota AJ. A health-related quality of life measure in patients with deep vein thrombosis: A validation study. Drug Inf J 1999;33: 1173-87.
61. Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000;32:130-7.